We can't find the internet
Attempting to reconnect
18117.1 PFLS-LS
STR001 as a Novel Treatment for Hearing Loss
Résumé
STR001 as a Novel Treatment for Hearing Loss
Textes supplémentaires
Abstract
STR001 is a drug that Strekin aims to develop for the treatment of hearing loss. Damage to sensory hair cells in the inner ear is a primary cause of sensorineural hearing loss. The proposed drug has been shown to activate a target that favorably affects pathways implicated in hearing health. In this project, we conduct translational preclinical research of STR001 to enable fast entry into clinical development and value creation.
Participants
Alexander Bausch
Wirtschaftspartner
alexander.bausch@strekin.com
Strekin AG Alexander Bausch Hochbergerstrasse 60C 4057 Basel BS CH
Daniel Bodmer
Kontaktperson
daniel.bodmer@usb.ch
Universitätsspital Basel Daniel Bodmer Hebelstrasse 20 4031 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-02-29
- Date de fin
- 2019-11-30
- Coûts totaux approuvés
- CHF 542745.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%